Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $488.77 and traded as high as $529.02. Intuitive Surgical shares last traded at $526.96, with a volume of 899,536 shares changing hands.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on ISRG. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Leerink Partners lifted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $554.17.
View Our Latest Report on ISRG
Intuitive Surgical Trading Down 1.5 %
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.
Insiders Place Their Bets
In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. The trade was a 26.54 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. SMART Wealth LLC purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $290,000. Exome Asset Management LLC raised its holdings in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Brass Tax Wealth Management Inc. lifted its stake in shares of Intuitive Surgical by 2.2% during the third quarter. Brass Tax Wealth Management Inc. now owns 2,558 shares of the medical equipment provider’s stock worth $1,257,000 after buying an additional 56 shares during the period. DGS Capital Management LLC grew its holdings in shares of Intuitive Surgical by 19.3% during the third quarter. DGS Capital Management LLC now owns 1,659 shares of the medical equipment provider’s stock valued at $815,000 after buying an additional 268 shares during the last quarter. Finally, Garde Capital Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $103,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- 5 discounted opportunities for dividend growth investors
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- Stock Splits, Do They Really Impact Investors?
- Micron: Why Now Is the Time to Be Brave
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.